Afatinib Suppliers & Bulk Manufacturers

Afatinib is used for the treatment of non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGFR) gene. It is also indicated for metastatic NSCLC and certain cases of squamous cell carcinoma of the lung. Afatinib helps block cancer cell growth by inhibiting EGFR and other related receptor tyrosine kinases.

Afatinib is made from the active ingredient afatinib dimaleate, which is an irreversible inhibitor of the ErbB family of receptors, including EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4).

The trade name of Afatinib is Gilotrif in the United States and Giotrif in the European Union and the United Kingdom.

Afatinib (Gilotrif/Giotrif) is developed and marketed by Boehringer Ingelheim Pharmaceuticals.

The generic name is Afatinib Dimaleate.

The brand names are Gilotrif and Giotrif.

Afatinib is manufactured by Boehringer Ingelheim at its facilities in Germany and the United States under strict international quality and regulatory standards.